our reported effectiveness at a lower than usual dose of erythromycin is probably explained by the following factors : the known susceptibility of group a streptococci to low concentrations of erythromycin , the uniform absorption of the estolate formulation of erythromycin , and adequate compliance in adhering to the treatment regimen by the majority of our patients .
C0014806
erythromycin
C0014809
estolate